CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...
Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...
On Friday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Moderna vaccine should now seek out a booster five months after ...
Moderna said on Monday its updated Covid-19 booster generated "significantly higher" neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier shot. The bivalent booster used ...
(NEXSTAR) – The Moderna COVID-19 remains effective even after 6 months, the company said in a Tuesday update on its ongoing clinical trials. The study looked at 33 healthy adult participants in the ...
Moderna's Covid-19 vaccine showed 93% efficacy against symptomatic disease through six months, and the company expects to complete its application for full approval from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results